Literature DB >> 3794725

D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding.

R A Lyon, M Titeler, L Bigornia, A S Schneider.   

Abstract

Although dopamine-containing cells are known to be present in sympathetic ganglia, the site of action and the role of dopamine in ganglion function remain obscure. In the present work, we evaluated the interaction of dopamine receptor ligands with particulate membrane fractions from bovine chromaffin cells and adrenal medullary homogenates using the D2 dopamine receptor radioligand [3H]N-methylspiperone ([3H]NMSP). Scatchard analysis of [3H]NMSP saturation experiments revealed a Bmax of 24.1 +/- 1.6 fmol/mg of protein and a KD of 0.23 +/- 0.03 nM in the particulate fraction from adrenal medulla homogenates and a Bmax of 26.5 +/- 2.7 fmol/mg of membrane protein and a KD of 0.25 +/- 0.02 nM in the particulate fraction prepared from isolated adrenal chromaffin cells. There were approximately 1,000 receptors/cell. There were no detectable levels of specific [3H]NMSP binding in the particulates prepared from adrenal cortical or capsular homogenates. Competition studies with the nonradioactive D2 receptor antagonists spiperone, chlorpromazine, and (-)-sulpiride revealed KI values of 0.28, 21, and 196 nM, respectively. The (+) isomer of butaclamol displayed a 604-fold higher affinity than the (-) isomer. Competition studies with the dopamine receptor agonists dopamine and apomorphine revealed affinities of 3,960 and 417 nM, respectively. A correlation coefficient of 0.96 was obtained in studies comparing the potencies of drugs in inhibiting specific [3H]NMSP binding in bovine adrenal medullary homogenates and in inhibiting specific [3H]NMSP binding to brain D2 dopamine receptors. In summary, radiolabeling studies using [3H]NMSP have revealed the presence of D2 dopamine receptors on bovine adrenal chromaffin cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794725     DOI: 10.1111/j.1471-4159.1987.tb04139.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

Authors:  E F Espejo; M C Gonzalez-Albo; J P Moraes; F El Banoua; J A Flores; I Caraballo
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.

Authors:  M Kujacic; K Svensson; L Löfberg; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Modulation of secretion by dopamine involves decreases in calcium and nicotinic currents in bovine chromaffin cells.

Authors:  J M Sontag; P Sanderson; M Klepper; D Aunis; K Takeda; M F Bader
Journal:  J Physiol       Date:  1990-08       Impact factor: 5.182

4.  Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.

Authors:  Young Joo Baek; Yoo Seong Seo; Dong Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

5.  Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.

Authors:  M Kujacic; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 6.  Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies.

Authors:  Emilio Fernandez-Espejo
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.